| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Martin WR |
The Nature of Opioid and LSD Receptors: Structural Activity Relationsh... |
QUASAR. Quantitative... |
1978 |
| Jasinski DR |
Interdisciplinary Studies on Phencyclidine at the Addiction Research C... |
Psychopharmacol.Bull... |
1980 |
| Jaffe JH, Kanzler M, Gree... |
Abuse potential of loperamide |
Clin Pharmacol Ther |
1980 |
| Ruffig DM, Domino EF |
Effects of Selected Opioid Agonists and Antagonists on DMT- and LSD-25... |
Psychopharmacology |
1981 |
| Domino EF, Ruffing DM |
Evidence for Opioids as Partial Antagonists for Indole Hallucinogens |
Psychopharmacology B... |
1982 |
| Shearman GT, Herz A |
Non-opioid Psychotomimetic-like Discriminative Stimulus Properties Of ... |
European Journal of ... |
1982 |
| Vaupel DB, Morton EC |
Anorexia and Hyperphagia Produced by Five Pharmacologic Classes of Hal... |
Pharmacology, Bioche... |
1982 |
| Arnerić SP, Maixner W, L... |
Structure-activity relationships of 2-aminotetralins and 2-aminoindane... |
Arch Int Pharmacodyn... |
1982 |
| Ruffing DM, Domino EF |
Interaction of Synthetic Opioid Metenkephalin Peptide Analogs, Lilly ... |
Psychopharmacology |
1983 |
| Mokler DJ, Commissaris R... |
Naloxone Alters the Effects of LSD, DOM and Quipazine on Operant Behav... |
Pharmacology Biochem... |
1984 |
| Knaus EE, Warren BK, Ondr... |
US Patent 4,468,403 : Analgesic Substituted Piperidylidine-2-sulfon(cy... |
USPTO |
1984 |
| Cheney BV, Szmuszkovicz J... |
Factors affecting binding of trans-N-[2-(methylamino)cyclohexyl]benzam... |
J Med Chem |
1985 |
| Pfeiffer A, Brantl V, Her... |
Psychotomimesis mediated by kappa opiate receptors. |
Science |
1986 |
| Gillman MA |
Nitrous oxide, an opioid addictive agent. Review of the evidence |
Am J Med |
1986 |
| Battaglia G, Brooks BP, K... |
Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at v... |
Eur J Pharmacol |
1988 |
| Buchanan JF, Brown CR |
'Designer drugs'. A problem in clinical toxicology |
Med Toxicol Adverse ... |
1988 |
| Fujimoto RA, Boxer J, Jac... |
Synthesis, opioid receptor binding profile, and antinociceptive activi... |
J Med Chem |
1989 |
| Miczek KA, Tidey JW |
Amphetamines: aggressive and social behavior |
NIDA Res Monogr |
1989 |
| Bailey PL, Streisand JB, ... |
Differences in magnitude and duration of opioid-induced respiratory de... |
Anesth Analg |
1990 |
| Kosten TR |
Neurobiology of abused drugs. Opioids and stimulants |
J Nerv Ment Dis |
1990 |
| Bilsky EJ, Hubbell CL, De... |
MDMA produces a conditioned place preference and elicits ejaculation i... |
Pharmacol Biochem Be... |
1991 |
| Negri L, Erspamer GF, Sev... |
Dermorphin-related peptides from the skin of Phyllomedusa bicolor and ... |
Proc Natl Acad Sci U... |
1992 |
| Daly JW, Caceres J, Moni ... |
Frog secretions and hunting magic in the upper Amazon: identification ... |
Proc Natl Acad Sci U... |
1992 |
| Sosnowski M |
Pain management: physiopathology, future research and endpoints |
Support Care Cancer |
1993 |
| Stohler R, Rommelspacher ... |
[Beta-carbolines (harman/norharman) are increased in heroin dependent ... |
Ther Umsch |
1993 |
| Azolosa JL, Stitzer ML, G... |
Opioid physical dependence development: effects of single versus repea... |
Psychopharmacology (... |
1994 |
| Smith ML, Hughes RO, Levi... |
Forensic drug testing for opiates. VI. Urine testing for hydromorphone... |
J Anal Toxicol |
1995 |
| Reid LD, Hubbell CL, Tsai... |
Naltrindole, a delta-opioid antagonist, blocks MDMA's ability to enhan... |
Pharmacol Biochem Be... |
1995 |
| Storrow AB, Magoon MR, No... |
The dextromethorphan defense: dextromethorphan and the opioid screen |
Acad Emerg Med |
1995 |
| Kintz P, Tracqui A, Mangi... |
Sweat testing in opioid users with a sweat patch |
J Anal Toxicol |
1996 |
| Reid LD, Hubbell CL, Tsai... |
Naltrindole, a delta-opioid antagonist, blocks MDMA's ability to enhan... |
Pharmacol Biochem Be... |
1996 |
| Robson P, Bruce M |
A comparison of 'visible' and 'invisible' users of amphetamine, cocain... |
Addiction |
1997 |
| Uhl M |
Determination of drugs in hair using GC/MS/MS |
Forensic Sci Int |
1997 |
| Krupitsky EM, Grinenko AY |
Ketamine psychedelic therapy KPT: a review of the results of ten years... |
J Psychoactive Drugs |
1997 |
| Paronis CA, Woods JH |
Ventilation in morphine-maintained rhesus monkeys I: Effects of naltre... |
J Pharmacol Exp Ther |
1997 |
| Paronis CA, Woods JH |
Ventilation in morphine-maintained rhesus monkeys II: Tolerance to the... |
J Pharmacol Exp Ther |
1997 |
| Moore KA, Kilbane EM, Jon... |
Tissue distribution of ketamine in a mixed drug fatality |
J Forensic Sci |
1997 |
| Narcessian EJ, Yoon HJ |
False-positive urine drug screen: beware the poppy seed bagel |
J Pain Symptom Manag... |
1997 |
| Schmidt-Mutter C, Pain L,... |
The anxiolytic effect of gamma-hydroxybutyrate in the elevated plus ma... |
Eur J Pharmacol |
1998 |
| Decker MW, Bannon AW, Buc... |
Antinociceptive effects of the novel neuronal nicotinic acetylcholine ... |
Eur J Pharmacol |
1998 |
| Gerak LR, Brandt MR, Fran... |
Studies on benzodiazepines and opioids administered alone and in combi... |
Psychopharmacology (... |
1998 |
| Thongpradichote S, Matsum... |
Identification of opioid receptor subtypes in antinociceptive actions ... |
Life Sci |
1998 |
| Essawi MY |
Fentanyl analogues with a modified propanamido group as potential affi... |
Pharmazie |
1999 |
| Yamamoto LT, Horie S, Tak... |
Opioid receptor agonistic characteristics of mitragynine pseudoindoxyl... |
Gen Pharmacol |
1999 |
| McFee RB, Mofenson HC, Ca... |
Dextromethorphan: Another 'Ecstasy'? |
Arch Fam Med |
2000 |
| Erdtmann-Vourliotis M, Ma... |
Prior experience of morphine application alters the c-fos response to ... |
Brain Res Mol Brain ... |
2000 |
| Takayama H, Aimi N, Sakai... |
Chemical studies on the analgesic indole alkaloids from the traditiona... |
Yakugaku Zasshi |
2000 |
| Walsh SL, Strain EC, Abre... |
Enadoline, a selective kappa opioid agonist: comparison with butorphan... |
Psychopharmacology (... |
2001 |
| Walsh SL, Geter-Douglas B... |
Enadoline and butorphanol: evaluation of kappa-agonists on cocaine pha... |
J Pharmacol Exp Ther |
2001 |
| Heinälä P, Alho H, Kiianm... |
Targeted use of naltrexone without prior detoxification in the treatme... |
J Clin Psychopharmac... |
2001 |
| Baumann MH, Pablo J, Ali ... |
Comparative neuropharmacology of ibogaine and its O-desmethyl metaboli... |
Alkaloids Chem Biol |
2001 |
| Roth BL, Baner K, Westkae... |
Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid... |
Proc Natl Acad Sci U... |
2002 |
| Latta KS, Ginsberg B, Bar... |
Meperidine: a critical review |
Am J Ther |
2002 |
| Takayama H, Ishikawa H, K... |
Studies on the synthesis and opioid agonistic activities of mitragynin... |
J Med Chem |
2002 |
| Tsuchiya S, Miyashita S, ... |
Effect of mitragynine, derived from Thai folk medicine, on gastric aci... |
Eur J Pharmacol |
2002 |
| Baker AK, Hoffmann VL, Me... |
Dextromethorphan and ketamine potentiate the antinociceptive effects o... |
Pharmacol Biochem Be... |
2002 |
| Benedetti F |
How the doctor's words affect the patient's brain |
Eval Health Prof |
2002 |
| Cone EJ, Fant RV, Rohay J... |
Oxycodone involvement in drug abuse deaths: a DAWN-based classificatio... |
J Anal Toxicol |
2003 |
| Sheffler DJ, Roth BL |
Salvinorin A: the 'magic mint' hallucinogen finds a molecular target i... |
Trends Pharmacol Sci |
2003 |
| Baker D, Pryce G, Giovann... |
The therapeutic potential of cannabis |
Lancet Neurol |
2003 |
| Vasconcelos SM, Rebouças... |
Antinociceptive activities of the hydroalcoholic extracts from Erythri... |
Biol Pharm Bull |
2003 |
| Drummer OH, Gerostamoulos... |
The incidence of drugs in drivers killed in Australian road traffic cr... |
Forensic Sci Int |
2003 |
| Compan V, Scearce-Levie K... |
Enkephalin contributes to the locomotor stimulating effects of 3,4-met... |
Eur J Neurosci |
2003 |
| Mowry M, Mosher M, Briner... |
Acute physiologic and chronic histologic changes in rats and mice expo... |
J Psychoactive Drugs |
2003 |
| Vecellio M, Schopper C, M... |
Neuropsychiatric consequences (atypical psychosis and complex-partial ... |
J Psychopharmacol |
2003 |
| Butelman ER, Harris TJ, K... |
The plant-derived hallucinogen, salvinorin A, produces kappa-opioid ag... |
Psychopharmacology (... |
2003 |
| Matsumoto K, Horie S, Ish... |
Antinociceptive effect of 7-hydroxymitragynine in mice: Discovery of a... |
Life Sci |
2004 |
| Chavkin C, Sud S, Jin W, ... |
Salvinorin A, an active component of the hallucinogenic sage salvia di... |
J Pharmacol Exp Ther |
2004 |
| Cone EJ, Fant RV, Rohay J... |
Oxycodone involvement in drug abuse deaths : II. Evidence for toxic mu... |
J Anal Toxicol |
2004 |
| Braida D, Iosue S, Pegori... |
Delta-9-Tetrahydrocannabinol-induced conditioned place preference and ... |
European Journal of ... |
2004 |
| Munro TA, Rizzacasa MA, R... |
Studies toward the pharmacophore of salvinorin A, a potent kappa opioi... |
J Med Chem |
2005 |
| Chen SL, Huang EY, Chow L... |
Dextromethorphan differentially affects opioid antinociception in rats |
Br J Pharmacol |
2005 |
| Lee DY, Karnati VV, He M,... |
Synthesis and in vitro pharmacological studies of new C(2) modified sa... |
Bioorg Med Chem Lett |
2005 |
| Lee DY, Ma Z, Liu-Chen LY... |
New neoclerodane diterpenoids isolated from the leaves of Salvia divin... |
Bioorg Med Chem |
2005 |
| Gillman PK |
Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity |
Br J Anaesth |
2005 |
| Schmidt MD, Schmidt MS, B... |
Pharmacokinetics of the plant-derived kappa-opioid hallucinogen salvin... |
Synapse |
2005 |
| Capasso R, Borrelli F, Ca... |
The hallucinogenic herb Salvia divinorum and its active ingredient sal... |
Neurogastroenterol M... |
2006 |
| Campos AR, Santos FA, Rao... |
Ketamine-induced potentiation of morphine analgesia in rat tail-flick ... |
Biol Pharm Bull |
2006 |
| Ott J |
Obviation of opioid withdrawal syndrome by concomitant administration ... |
J Psychoactive Drugs |
2006 |
| Ellgren M, Spano SM, Hurd... |
Adolescent Cannabis Exposure Alters Opiate Intake and Opioid Limbic Ne... |
Neuropsychopharmacol... |
2006 |
| Terner JM, de Wit H |
Menstrual cycle phase and responses to drugs of abuse in humans |
Drug Alcohol Depend |
2006 |
| Butelman ER, Mandau M, Ti... |
Effects of salvinorin A, a kappa-opioid hallucinogen, on a neuroendocr... |
J Pharmacol Exp Ther |
2007 |
| Rothman RB, Murphy DL, Xu... |
Salvinorin A: Allosteric Interactions at the {micro}-Opioid Receptor |
J Pharmacol Exp Ther |
2007 |
| Braida D, Limonta V, Pego... |
Hallucinatory and rewarding effect of salvinorin A in zebrafish: kappa... |
Psychopharmacology (... |
2007 |
| Scheerer JR, Lawrence JF,... |
Asymmetric Synthesis of Salvinorin A, A Potent K Opioid Receptor Agoni... |
JACS |
2007 |
| Haney M |
Opioid Antagonism of Cannabinoid Effects: Differences between Marijuan... |
Neuropsychopharmacol... |
2007 |
| Mintzer IL, Eisenberg M, ... |
Treating opioid addiction with buprenorphine-naloxone in community-bas... |
Ann Fam Med |
2007 |
| Wager TD, Scott DJ, Zubie... |
Placebo effects on human {micro}-opioid activity during pain |
Proc Natl Acad Sci U... |
2007 |
| Panchal SJ, Müller-Schwef... |
Opioid-induced bowel dysfunction: prevalence, pathophysiology and burd... |
Int J Clin Pract |
2007 |
| Nocjar C, Panksepp J |
Prior morphine experience induces long-term increases in social intere... |
Behav Brain Res |
2007 |
| Alper KR, Lotsof HS, Kapl... |
The ibogaine medical subculture |
J Ethnopharmacol |
2007 |
| Grundmann O, Phipps SM, Z... |
Salvia divinorum and salvinorin A: an update on pharmacology and analy... |
Planta Med |
2007 |
| Chyka PA, Erdman AR, Mano... |
Dextromethorphan poisoning: an evidence-based consensus guideline for ... |
Clin Toxicol |
2007 |
| Boyer EW, Babu KM, Macali... |
Self-treatment of opioid withdrawal with a dietary supplement, Kratom |
Am J Addict |
2007 |
| Shields LB, Hunsaker Iii ... |
Methadone toxicity fatalities: a review of medical examiner cases in a... |
J Forensic Sci |
2007 |
| Munro TA, Duncan KK, Xu W... |
Standard protecting groups create potent and selective kappa opioids: ... |
Bioorg Med Chem |
2008 |
| Babu KM, McCurdy CR, Boye... |
Opioid receptors and legal highs: Salvia divinorum and Kratom |
Clin Toxicol (Phila) |
2008 |
| Farouk L, Laroubi A, Abou... |
Evaluation of the analgesic effect of alkaloid extract of Peganum harm... |
J Ethnopharmacol |
2008 |
| Hooker JM, Xu Y, Schiffer... |
Pharmacokinetics of the potent hallucinogen, salvinorin A in primates ... |
Neuroimage |
2008 |
| Wang Y, Chen Y, Xu W, Lee... |
2-Methoxymethyl-salvinorin B is a potent kappa opioid receptor agonist... |
J Pharmacol Exp Ther |
2008 |
